GPR39 and atherosclerosis: A recent study pointed out that agonizing the G protein-coupled receptor 39 (GPR39) weakens oxidized low-density lipoprotein (ox-LDL)-induced attachment of monocytes to vascular endothelial cells and thus alleviates atherosclerosis [17].